Tech Company Financing Transactions
ProCertus BioPharm Funding Round
Venture Investors and Novartis BioVenture Fund joined a $2.3 million Series A capital raise for ProCertus BioPharm. The financing was announced on 5/10/2007.
Transaction Overview
Company Name
Announced On
5/10/2007
Transaction Type
Venture Equity
Amount
$2,300,000
Round
Series A
Investors
Venture Investors (Lead Investor) (George Arida)
Proceeds Purpose
ProCertus will initiate Phase I/II clinical studies to demonstrate proof of concept in humans for its chemo- and radioprotective products, the first of which -- DermX -- has been developed for the prevention of radiotherapy-induced dermatitis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
510 Charmany Dr. 175 B
Madison, WI 53719
USA
Madison, WI 53719
USA
Phone
Website
Email Address
Overview
ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Weiss
Chief Scientific Officer
William Fahl
VP - Finance
Todd Argall
Browse more venture capital transactions:
Prev: 5/10/2007: StrongMail Systems venture capital transaction
Next: 5/10/2007: SpringSource venture capital transaction
Share this article
Where The Data Comes From
We do our best to record all VC transactions involving tech companies. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs